Animal Health
North America Vet Compounding Pharmacies Market

North America Vet Compounding Pharmacies Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

North America Vet Compounding Pharmacies Market by Product Type (CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), Animal Type, Formulation, and Regional Analysis from 2025 - 2032

ID: PMRREP33001

December 2025

161 Pages

Author : Pravin Rewale

Healthcare

Key Industry Highlights:

Increasing pet ownership across the U.S. and Canada is driving demand for veterinary care and compounded medications.
The U.S. leads North America due to advanced veterinary infrastructure, high disposable income, and pet health awareness. It accounts for the largest share of veterinary compounding pharmacy revenue in the region.
Canada is witnessing a rise in the adoption of compounded medications, driven by expanding veterinary clinics, increased pet ownership, and greater awareness of tailored therapy options for animals.
CNS agents, including medications for neurological disorders, anxiety, pain management, and behavioral issues in pets, are widely prescribed and frequently compounded to provide species-specific dosages and formulations.

Key Insights	Details
Vet Compounding Pharmacies Market Size (2025E)	US$1.6 Bn
Market Value Forecast (2032F)	US$2.7 Bn
Projected Growth (CAGR 2025 to 2032)	7.6%
Historical Market Growth (CAGR 2019 to 2024)	7.3%

north-america-vet-compounding-pharmacies-market-2025–2032

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Higher Level of Veterinary Care Due to Increased Owner Awareness

Factors encouraging the growth of vet compounding pharmacies include the increasing humanization of pets, the expanding adoption of animals in the region, and the growing online influx of medical information. In 2020, almost 84.9 million households had pets, according to the American Pet Product Association and the American Veterinary Medical Association (AVMA). About 34% of households have cats as pets, compared to 50% of U.S. families who own dogs. With ready access to information, pet owners are more aware than ever, increasing demand for high-quality veterinary care. As a result, rising pet adoption is expected to drive demand for vet compounding pharmacies in the future.

Restraints - Safety and Skill-Related Barriers

Both unsafe compounding practices and a lack of trained veterinary professionals constrain the growth of veterinary compounding pharmacies. Contamination during compounding, non-compliance with cGMP standards, and inadequate sterile environments increase the risk of infections, adverse drug reactions, and fatalities. Simultaneously, many veterinarians lack specialized training in veterinary-specific pharmaceutical compounding, leading to errors, incorrect dosing, and potentially harmful prescriptions. Together, these factors limit the safe and widespread adoption of compounded medications, highlighting the critical need for stringent regulatory compliance, proper facility standards, and enhanced interdisciplinary training for veterinary compounding personnel.

Opportunity - Personalized Medications for Chronic Pet Conditions

The rising prevalence of chronic diseases in companion animals, including diabetes, arthritis, and kidney disorders, is creating a significant demand for personalized veterinary medications. Standard dosages often do not meet the unique needs of individual pets, making compounded formulations essential for precise, species-specific treatment. Veterinary compounding pharmacies can develop customized strengths, dosage forms, and administration routes, improving therapeutic efficacy and compliance. These tailored solutions allow pets to receive safer, more effective care, particularly for long-term management of chronic conditions. As the awareness grows among pet owners, the demand for individualized, high-quality compounded medications continues to expand across North America.

Category-wise Analysis

By Product Type Insights

The CNS Agents segment dominates the North America veterinary compounding pharmacies market due to the high prevalence of neurological, behavioral, and pain-related disorders in companion animals. Pets often require precise, species-specific dosing for conditions such as anxiety, epilepsy, and chronic pain, which cannot always be met with commercially available medications. Veterinary compounding pharmacies provide customized CNS formulations—including oral suspensions, flavored tablets, and transdermal gels that enhance compliance and therapeutic efficacy. The consistent demand from pet owners seeking effective management of behavioral and neurological conditions, combined with the need for personalized dosing, positions CNS agents as the leading and most widely adopted product segment in the market.

By Formulation Insights

The oral formulation segment leads the North America veterinary compounding pharmacies market due to its convenience, ease of administration, and high compliance among companion animals. Flavored suspensions, chewable tablets, and species-specific oral solutions allow precise dosing for chronic conditions such as diabetes, arthritis, and behavioral disorders, which require long-term therapy. Oral formulations reduce stress for pets and simplify medication administration for owners, making them more practical than injectables or other specialized forms. Additionally, their versatility across multiple therapeutic categories, including CNS agents, anti-infectives, and hormones, further drives demand, establishing oral formulations as the preferred and highest-share segment in the veterinary compounding market.

north-america-vet-compounding-pharmacies-market-by-product-type-2025–2032

Request Free sampleRequest Free sample

Country-wise Insights

U.S. Vet Compounding Pharmacies Market Trends

The U.S. veterinary compounding pharmacies market is experiencing robust growth, driven by rising pet ownership, the growing prevalence of chronic animal diseases, and demand for personalized medications. Flavor-tailored oral formulations, small-batch compounding, and sterile injectable drugs are gaining prominence to enhance compliance and therapeutic outcomes. Regulatory oversight from the FDA, including cGMP certification for outsourcing facilities, ensures safety and quality, boosting market confidence. Advances in technology, such as automated compounding and precision dosing equipment, are improving efficiency and consistency. Additionally, expanding veterinary clinics, telemedicine services, and awareness of specialized treatments are driving the adoption of compounded medications, positioning the U.S. as a leading global market.

Competitive Landscape

The North American veterinary compounding pharmacies market is highly competitive, with a mix of large-scale compounding facilities, regional players, and specialized boutique pharmacies. Key players focus on differentiating through customized formulations, flavor-enhanced medications, sterile injectables, and advanced oral preparations to meet diverse veterinary needs. Strategic partnerships with veterinary clinics, hospitals, and telemedicine providers enhance market reach and client retention.

Key Industry Developments:

In January 2025, Revelation Pharma launched its new animal-focused division, Revelation Animal Health, a dedicated arm aimed at serving the unique health needs of animals across the nation.

Companies Covered in North America Vet Compounding Pharmacies Market

Hoye’s Pharmacy
Vertisis Custom Pharmacy
Smith Caldwell Drug Store
Sixth Avenue Medical Pharmacy
Dougherty Pharmacy
Triangle Compounding Pharmacy Inc.,
Wedgewood Pharmacy
Millers Pharmacy
Chiron Compounding Pharmacy
MEDS Canadian Compounding Pharmacy
Aurora Compounding
Pace Pharmacy
Victoria Compounding Pharmacy
Pratt’s Compounding Pharmacy
People’s Choice Pharmacy
Others

Frequently Asked Questions

The North America vet compounding pharmacies market is valued at US$1.6 Bn in 2025.

Increasing numbers of companion animals boost demand for veterinary care and customized medications.

The market is poised to witness a CAGR of 7.6% between 2025 and 2032.

Custom formulations for pets with diabetes, arthritis, or kidney disorders.

Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, Sixth Avenue Medical Pharmacy, and others.

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis	Value: US$ Bn
Geographical Coverage	North America
Segmental Coverage	By Product Type By Animal Type By Formulation By Country
Competitive Analysis	Hoye’s Pharmacy Vertisis Custom Pharmacy Smith Caldwell Drug Store Sixth Avenue Medical Pharmacy Dougherty Pharmacy Triangle Compounding Pharmacy Inc., Wedgewood Pharmacy Millers Pharmacy Chiron Compounding Pharmacy MEDS Canadian Compounding Pharmacy Aurora Compounding Pace Pharmacy Victoria Compounding Pharmacy Pratt’s Compounding Pharmacy People’s Choice Pharmacy Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Vet Compounding Pharmacies Market Size (2025E)

US$1.6 Bn

Market Value Forecast (2032F)

US$2.7 Bn

Projected Growth (CAGR 2025 to 2032)

7.6%

Historical Market Growth (CAGR 2019 to 2024)

7.3%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis	Value: US$ Bn
Geographical Coverage	North America
Segmental Coverage	By Product Type By Animal Type By Formulation By Country
Competitive Analysis	Hoye’s Pharmacy Vertisis Custom Pharmacy Smith Caldwell Drug Store Sixth Avenue Medical Pharmacy Dougherty Pharmacy Triangle Compounding Pharmacy Inc., Wedgewood Pharmacy Millers Pharmacy Chiron Compounding Pharmacy MEDS Canadian Compounding Pharmacy Aurora Compounding Pace Pharmacy Victoria Compounding Pharmacy Pratt’s Compounding Pharmacy People’s Choice Pharmacy Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Executive Summary
1. North America Vet Compounding Pharmacies Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global GDP Growth Outlook
  2. Global Healthcare Spending Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Type Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
North America Vet Compounding Pharmacies Market Outlook
1. North America Vet Compounding Pharmacies Market Outlook: Product Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019 - 2023
  3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025 - 2032
    1. CNS Agents
    2. Anti-Infective Agents
    3. Hormones and Substitutes
    4. Anti-inflammatory Agents
    5. Others
  4. Market Attractiveness Analysis: Product Type
2. North America Vet Compounding Pharmacies Market Outlook: Animal Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Animal Type, 2019 - 2023
  3. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025 - 2032
    1. Companion Animals
    2. Dogs
    3. Cats
    4. Others
    5. Livestock Animals
  4. Market Attractiveness Analysis: Animal Type
3. North America Vet Compounding Pharmacies Market Outlook: Formulation
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Formulation, 2019 - 2023
  3. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
    1. Oral
    2. Injectable
    3. Others
  4. Market Attractiveness Analysis: Formulation
North America Vet Compounding Pharmacies Market Outlook: Country
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Country, 2019 - 2023
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Market Attractiveness Analysis: Country
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Hoye’s Pharmacy
    1. Overview
    2. Segments and Product Types
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Vertisis Custom Pharmacy
  3. Smith Caldwell Drug Store
  4. Sixth Avenue Medical Pharmacy
  5. Dougherty Pharmacy
  6. Triangle Compounding Pharmacy Inc.,
  7. Wedgewood Pharmacy
  8. Millers Pharmacy
  9. Chiron Compounding Pharmacy
  10. MEDS Canadian Compounding Pharmacy
  11. Aurora Compounding
  12. Pace Pharmacy
  13. Victoria Compounding Pharmacy
  14. Pratt’s Compounding Pharmacy
  15. People’s Choice Pharmacy
  16. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

North America Vet Compounding Pharmacies Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

North America Vet Compounding Pharmacies Market by Product Type (CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), Animal Type, Formulation, and Regional Analysis from 2025 - 2032